Journal of Pain and Symptom Management
Volume 32, Issue 6 , Pages 541-550 , December 2006

A Randomized, Double-Blind, Crossover Trial of the Effect of Oxygen on Dyspnea in Patients with Advanced Cancer

,Accepted 24 June 2006.

References 

  1. Donnelly S, Walsh D. The symptoms of advanced cancer. Semin Oncol. 1995;22:67–72
  2. Forster L, Lynn J. Predicting life span for applicants to inpatient hospice. Arch Intern Med. 1988;148:2540–2543
  3. Hayes A, Philip J, Spruyt O. Patient reporting and doctor recognition of dyspnea in a comprehensive cancer center. Intern Med J. 2006;36:381–384
  4. Krech RL, Walsh D. Symptoms of pancreatic cancer. J Pain Symptom Manage. 1991;6:360–367
  5. Mercadante S, Armata M, Salvaggio L. Pain characteristics of advanced lung cancer patients referred to a palliative care service. Pain. 1994;59:141–145
  6. Escalante CP, Martin CG, Elting LS, et al. Dyspnea in cancer patients. Aetiology, resource utilization, and survival—implications in a managed care world. Cancer. 1996;78:1314–1319
  7. American Thoracic Society . Dyspnea. Mechanisms, assessment and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med. 1999;159:321–340
  8. McClosky DI. Kinesthetic sensibility. Physiol Rev. 1978;58:763–820
  9. Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological interventions for breathlessness in lung cancer. Palliat Med. 1996;10:299–305
  10. Filshie J, Davis CL, Van Der Molen B. The short term effects of acupuncture in terminal dyspnea. Palliat Med. 1996;10:145–150
  11. Ahmedzai S, Davis CL. Nebulized drugs in palliative care. Thorax. 1997;52:S57–S77
  12. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990;5:341–344
  13. Bruera E, MacEachern T, Ripamonti C, Hanson J. Subcutaneous morphine for dyspnea in cancer patients. Ann Intern Med. 1993;119:906–907
  14. Cowcher K, Hanks GWC. Long-term management of respiratory symptoms in advanced cancer. J Pain Symptom Manage. 1990;5:320–330
  15. Light RW, Muro JR, Sato RI, et al. Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease. Am Review Respir Med. 1989;139:126–133
  16. Walsh D. Dyspnea in advanced cancer. Lancet. 1993;342:450–451
  17. Woodcock A, Gross ER, Gellert A, et al. Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases. N Engl J Med. 1981;305:1611–1616
  18. O'Donohue WJ. Home oxygen therapy. Med Clin North Am. 1996;80:611–622
  19. Bruera E, de Stoutz N, Velasco-Leiva A, Schoeller T, Hanson J. Effects of oxygen on dyspnea in hypoxaemic terminal-cancer patients. Lancet. 1993;342:13–14
  20. Booth S, Kelly MJ, Cox NP, Adams L. The treatment of dyspnea in cancer patients—does oxygen help?. Prog Palliat Care. 1994;2:8
  21. Katzman R, Brown T, Fuld P, et al. Validation of a short orientation memory concentration test of cognitive impairment. Am J Psychiatry. 1983;140:734–739
  22. Bergman B, Aaronson N, Ahmedzai S, et al. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer. 1994;30A:635–642
  23. Heyse-Moore L. Two new measures of dyspnea in advanced cancer. Prog Palliat Care. 1994;2:8
  24. Jones B, Kenward MG. Design and analysis of cross-over trials. London: Chapman and Hall Ltd.; 1989;
  25. Maddocks I. Issues in the conduct of therapeutic trials in palliative care: an Australian perspective. Drugs Aging. 2002;19:495–502
  26. Rinck G, van den Bos G, Kleijnen J, de Haes H, Schade E. Methodologic issues in effectiveness research on palliative care patients: a systematic review. J Clin Oncol. 1997;15:1697–1707
  27. Hudson P, Aranda S, Kristjanson L. Randomised controlled trials in palliative care: overcoming the barriers. Int J Palliat Nurs. 2001;7:427–434
  28. Bottomley A. To randomise or not to randomise: methodological pitfalls of the RCT design in psychosocial intervention studies. Eur J Cancer Care. 1997;6:222–230
  29. Heyse-Moore L, Beyon T, Ross V. Does spirometry predict dyspnea in advanced cancer?. Palliat Med. 2000;14:189–195
  30. Simon PM, Basner RC, Weinberger SE, et al. Oral mucosal stimulation modulates intensity of breathlessness induced in normal subjects. Am Rev Respir Dis. 1991;144:419–422
  31. Schwartzstein RM, Lahive K, Pope A, Weinberger SE, Weiss JW. Cold facial stimulation reduces breathlessness induced in normal subjects. Am Rev Respir Dis. 1987;136:58–61
  32. Liss HP, Grant BJ. The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;137:1285–1288
  33. Farrar JT, Portenoy RK, Berlin JA, Kinman JL, Strom BL. Defining the clinically important difference in pain outcome measures. Pain. 2000;88:287–294

 This research was made possible through grants from the Australian New Zealand Society of Palliative Medicine and The Bethlehem Griffiths Research Foundation. The authors have no conflicts of interest to declare.

PII: S0885-3924(06)00550-1

doi: 10.1016/j.jpainsymman.2006.06.009

Journal of Pain and Symptom Management
Volume 32, Issue 6 , Pages 541-550 , December 2006

Article Tools

* Image Usage & Resolution